Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

ALAN PIERRE ZAUSNER SKARBNIK

Allopathic & Osteopathic Physicians Internal Medicine Hematology

NPI
1366754954
CMS profile
914590
Location
CHARLOTTE, NC

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2024 · Entire year

$129,388.89

113 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

Other CMS categories — not shown on this page

Research Payments

CMS also publishes Research Payments as a separate dataset. This site does not currently mirror it, and no research figure is shown on this page. This provider appears in that dataset.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

These records are published by CMS and can be viewed on this provider’s official CMS record. View this provider on CMS Open Payments ↗

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2024 · entire year · sorted by reported total

By paying entity

PY2024 · entire year · sorted by reported total

Paying entityAmountRecords
AstraZeneca Pharmaceuticals LP $53,982.20 44
Lilly USA, LLC $16,248.68 11
ABBVIE INC. $13,645.72 15
E.R. Squibb & Sons, L.L.C. $10,804.41 9
JAZZ PHARMACEUTICALS INC. $9,635.86 7
ADC Therapeutics America, Inc. $9,461.17 4
Kite Pharma, Inc. $8,725.61 4
AstraZeneca UK Limited $4,845.00 3
Genmab U.S., Inc. $1,010.95 7
Celgene Corporation $638.46 3
Genentech USA, Inc. $122.53 1
PFIZER INC. $116.98 1
Epizyme, Inc. $88.65 1
Genentech, Inc. $30.59 1
Novartis Pharmaceuticals Corporation $18.56 1
Eli Lilly and Company $13.52 1

Payment records · PY2024

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2024 · Physicians and non-physician practitioners · CMS publication 2026-06-30

113 matching records · $129,388.89 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 113 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 1–50 of 113.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Kite Pharma, Inc. $5,090.0012/17/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/20261128610605 CMS
AstraZeneca Pharmaceuticals LP $4,920.0012/12/2024 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261105443015 CMS
AstraZeneca Pharmaceuticals LP $4,100.0012/12/2024 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261105515455 CMS
Lilly USA, LLC $800.0012/12/2024 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261136014142 CMS
Lilly USA, LLC $2,800.0012/12/2024 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261136017921 CMS
AstraZeneca Pharmaceuticals LP $2,460.0012/10/2024 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261105610137 CMS
AstraZeneca Pharmaceuticals LP $60.0012/09/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261104594282 CMS
Celgene Corporation $38.4612/09/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261101107254 CMS
Genmab U.S., Inc. $112.9312/09/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261126823892 CMS
Genmab U.S., Inc. $33.3412/09/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261126823898 CMS
Lilly USA, LLC $112.0012/09/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261136014144 CMS
AstraZeneca Pharmaceuticals LP $82.9512/08/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261105865022 CMS
Genentech, Inc. $30.5912/08/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261132973449 CMS
Lilly USA, LLC $136.6812/08/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261136013886 CMS
ABBVIE INC. $13.6812/07/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261106116879 CMS
ABBVIE INC. $50.0012/07/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261106116881 CMS
ABBVIE INC. $124.1712/06/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261106116877 CMS
AstraZeneca Pharmaceuticals LP $87.0012/05/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261104542520 CMS
AstraZeneca UK Limited $50.0012/05/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261093953717 CMS
JAZZ PHARMACEUTICALS INC. $4,140.0012/04/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/20261150211919 CMS
ABBVIE INC. $1,650.0012/03/2024 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261106116875 CMS
Kite Pharma, Inc. $130.9912/03/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261128610603 CMS
Kite Pharma, Inc. $854.6212/03/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/20261128610607 CMS
AstraZeneca UK Limited $2,740.0011/27/2024 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261093911691 CMS
JAZZ PHARMACEUTICALS INC. $1,319.1711/26/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/20261150211917 CMS
E.R. Squibb & Sons, L.L.C. $5,082.0011/25/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/20261101315658 CMS
JAZZ PHARMACEUTICALS INC. $347.7011/23/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/20261150211915 CMS
JAZZ PHARMACEUTICALS INC. $144.7211/22/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261150211923 CMS
ADC Therapeutics America, Inc. $1,318.9811/20/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/20261121185942 CMS
ADC Therapeutics America, Inc. $7,300.0011/19/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/20261121185940 CMS
ADC Therapeutics America, Inc. $112.1911/15/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261121185938 CMS
Genmab U.S., Inc. $135.0011/11/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261126823890 CMS
JAZZ PHARMACEUTICALS INC. $3,220.0011/04/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/20261150211913 CMS
E.R. Squibb & Sons, L.L.C. $733.1210/29/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/20261101315660 CMS
E.R. Squibb & Sons, L.L.C. $124.9210/29/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261101315662 CMS
E.R. Squibb & Sons, L.L.C. $182.8010/29/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/20261101315664 CMS
E.R. Squibb & Sons, L.L.C. $800.5210/29/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/20261101315666 CMS
AstraZeneca Pharmaceuticals LP $127.5110/28/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261105730313 CMS
Genmab U.S., Inc. $55.5610/25/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261126823894 CMS
JAZZ PHARMACEUTICALS INC. $342.4710/24/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/20261150211921 CMS
JAZZ PHARMACEUTICALS INC. $121.8010/18/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261150211911 CMS
Lilly USA, LLC $1,600.0010/18/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/20261136016549 CMS
Lilly USA, LLC $800.0010/11/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/20261136015433 CMS
AstraZeneca Pharmaceuticals LP $128.8410/04/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261105557810 CMS
Lilly USA, LLC $2,400.0009/25/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/20261135995890 CMS
E.R. Squibb & Sons, L.L.C. $3,176.0009/16/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/20261101315642 CMS
AstraZeneca Pharmaceuticals LP $23.8208/29/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261104385763 CMS
AstraZeneca Pharmaceuticals LP $117.9708/29/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261104390705 CMS
AstraZeneca Pharmaceuticals LP $24.0508/29/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261105551090 CMS
AstraZeneca Pharmaceuticals LP $40.7208/29/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261105691577 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $154,772.34 157
PY2020 $77,277.54 62
PY2021 $135,844.88 107
PY2022 $173,706.19 115
PY2023 $241,561.60 171
PY2024 $129,388.89 113
PY2025 $171,893.70 156

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Cite this record.

Plain
ALAN PIERRE ZAUSNER SKARBNIK, NPI 1366754954. IndustryPayments, data edition 2026-07-26T04:22:22Z. https://industrypayments.org/provider/npi-1366754954.
APA 7
IndustryPayments. (2026). ALAN PIERRE ZAUSNER SKARBNIK, NPI 1366754954 (Data edition 2026-07-26T04:22:22Z) [Data set]. https://industrypayments.org/provider/npi-1366754954
Bluebook
ALAN PIERRE ZAUSNER SKARBNIK, NPI 1366754954, IndustryPayments (data edition 2026-07-26T04:22:22Z), https://industrypayments.org/provider/npi-1366754954.

Source: Centers for Medicare & Medicaid Services, Open Payments.